CencoraCOREarnings & Financial Report
Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale and distribution company and a contract research organization, that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. It was renamed to Cencora in 2023. Cencora is one of the largest pharmaceutical companies in the world and distributes generic pharmaceuticals, over-the-counter healthcare products, as well as home healthcare supplies and equipment.
COR Q1 2026 Key Financial Metrics
売上高
$85.9B
粗利益
$3.1B
営業利益
$760.4M
純利益
$559.6M
粗利益率
3.6%
営業利益率
0.9%
純利益率
0.7%
前年比成長
13.9%
EPS
$2.87
資金フロー
Cencora Q1 2026 Financial Summary
Cencora reported revenue of $85.9B for Q1 2026, with a net profit of $559.6M (0.7% margin). Cost of goods sold was $82.9B, operating expenses totaled $2.3B.
Key Financial Metrics
| Total Revenue | $85.9B |
|---|---|
| Net Profit | $559.6M |
| Gross Margin | 3.6% |
| Operating Margin | 0.9% |
| Report Period | Q1 2026 |
Cencora Annual Revenue by Year
Cencora annual revenue history includes year-by-year totals (for example, 2025 revenue was $322.7B).
| Year | Annual Revenue |
|---|---|
| 2025 | $322.7B |
| 2024 | $298.4B |
| 2023 | $269.6B |
| 2022 | $240.7B |
損益計算書
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| 売上高 | $74.24B | $74.24B | $81.49B | $75.45B | $80.66B | $80.66B | $85.93B | $85.93B |
| 前年比成長 | 10.9% | 10.9% | 12.8% | 10.3% | 8.7% | 8.7% | 5.5% | 13.9% |
貸借対照表
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| 総資産 | $66.77B | $67.10B | $69.05B | $71.19B | $73.96B | $76.59B | $78.36B | $78.36B |
| 総負債 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| 株主資本 | $925.2M | $645.9M | $226.6M | $1.01B | $1.98B | $1.51B | $1.91B | $1.91B |
キャッシュフロー
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| 営業CF | $2.48B | $1.00B | $-2.72B | $3.35B | $109.2M | $3.13B | $-2.31B | $-2.31B |
Other Health Care Companies
CAH
Cardinal Health
売上高
$65.6B
純利益
$467.0M
HSIC
Henry Schein
売上高
$3.3B
純利益
$101.0M
MCK
McKesson Corporation
売上高
$106.2B
純利益
$1.2B
ABT
Abbott Laboratories
売上高
$11.4B
純利益
$1.6B
ABBV
AbbVie
売上高
$15.8B
純利益
$186.0M
A
Agilent Technologies
売上高
$1.9B
純利益
$434.0M
ALGN
Align Technology
売上高
$995.7M
純利益
$56.8M
AMGN
Amgen
売上高
$9.9B
純利益
$1.3B
BAX
Baxter International
売上高
$3.0B
純利益
$-1.1B
BDX
Becton Dickinson
売上高
$5.3B
純利益
$382.0M